Positive Airway Pressure Therapy in Sleep-Disordered Breathing.

Abstract

Obstructive sleep apnea (OSA) is a highly prevalent condition with major neurocognitive and cardiovascular health effects. Positive airway pressure (PAP) therapy prevents the collapse of the pharyngeal airway to improve hypoxemia, hypercapnia, and sleep fragmentation caused by OSA. While adherence to PAP therapy has been thought to be a barrier to use, consistent usage is likely much higher than commonly thought. In addition, many strategies have been developed to assist providers in improving their patients' PAP adherence.

• Authors: Janna R Raphelson, Kimberly Y Kreitinger, Atul Malhotra
• Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics (Neurotherapeutics) Vol. 18 Issue 1 Pg. 75-80 (01 2021) ISSN: 1878-7479 [Electronic] United States
• PMID: 33230691 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Review)

Topics

• Continuous Positive Airway Pressure (methods)
• Humans
• Patient Compliance
• Sleep Apnea Syndromes (therapy)
• Treatment Outcome